Table 3.
Medication exposure during the first 7 days
| Medication | Personalized music (n = 16) |
Relaxing slow-tempo music (n = 16) |
Audiobook (attention control) (n = 15) |
pa |
|---|---|---|---|---|
| Benzodiazepines | ||||
| Patients, No. (%) | 7 (44) | 9 (56) | 9 (60) | .63 |
| Daily dose,b mean (SD) | 2.6 (3.3) | 10.7 (26.4) | 13.9 (36.8) | .71 |
| Dexmedetomidine | ||||
| Patients, No. (%) | 1 (6) | 2 (12) | 1 (7) | >.99c |
| Daily dose, mean (SD), mg | 0.2 (0.0) | 0.2 (0.2) | 0.3 (0.0) | .90 |
| Haloperidol | ||||
| Patients, No. (%) | 2 (12) | 1 (6) | 3 (20) | .50c |
| Daily dose, mean (SD), mg | 1.2 (0.5) | 0.7 (0.0) | 2.1 (1.7) | .67 |
| Ketamine | ||||
| Patients, No. (%) | 1 (6) | 3 (19) | 3 (20) | .60c |
| Daily dose, mean (SD), mg | 1.4 (0.0) | 413.3 (517.2) | 3594.7 (3599.2) | .34 |
| Opioids | ||||
| Patients, No. (%) | 14 (88) | 15 (94) | 14 (93) | .78 |
| Daily dose,d mean (SD) | 116.9 (90.1) | 85 (129.4) | 111.4 (122.4) | .73 |
| Propofol | ||||
| Patients, No. (%) | 7 (44) | 8 (50) | 8 (53) | .86 |
| Daily dose, mean (SD), mg | 1383.9 (2178.7) | 620.8 (697.8) | 1157.7 (1375.0) | .61 |
| Quetiapine | ||||
| Patients, No. (%) | 3 (19) | 0 (0) | 3 (20) | .19c |
| Daily dose, mean (SD), mg | 111.9 (41.2) | 0.0 (0.0) | 42.9 (18.9) | .06 |
a
Unless otherwise indicated, mean (SD) values were compared using analysis of variance and No. (%) values were compared using χ2 test.
b
Dose in lorazepam equivalents.
c
Fisher exact test.
d
Dose in morphine intravenous equivalents.